Evidence map›Paper›PMID 36540152›Full record

ArticleNeurology. Clinical practice2022

Inpatient Teleneurology Follow-up Has Comparable Outcomes to In-Person Neurology Follow-up.

Alicia M Zha, Alyssa D Trevino, Christy M Ankrom, Kristie M Chu, Michele M Joseph, Tushar Patni, Tiffany D Cossey, Sean I Savitz, Tzu-Ching Wu, Amanda Jagolino-Cole

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alicia M ZhaDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Alyssa D TrevinoDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Christy M AnkromDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Kristie M ChuDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Michele M JosephDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Tushar PatniDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Tiffany D CosseyDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.ORCID https://orcid.org/0000-0002-1261-3432
Sean I SavitzDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Tzu-Ching WuDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.
Amanda Jagolino-ColeDepartment of Neurology (AMZ, ADT, SIS, AJ-C), University of Texas McGovern Medical School, Houston; Department of Neurology (AMZ), The Ohio State University Wexner Medical Center, Columbus; Current Neurology Solutions (CMA, KMC, MMJ, TDC, T-CW), Pearland TX; Department of Biostatistics (TP), St. Jude Children's Research Hospital, Memphis, TN; and Institute of Stroke and Cerebrovascular Disease (SIS, AJ-C), Department of Neurology, University of Texas McGovern Medical School, Houston.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Community emergency departments often transfer patients for lack of neurology coverage, potentially burdening patients and accepting facilities. Telestroke improves access to acute stroke care, but there is a lack of data on inpatient teleneurology and telestroke care. Methods: From our prospective telestroke registry, we retrospectively reviewed 3702 consecutive patients who were seen via telestroke between September 2015 and December 2018. Patients who required transfer after initial telestroke evaluation or who were kept at hospitals without consistent neurology coverage were excluded from analysis. We compared baseline demographics, clinical characteristics, and hospital outcomes in patients who were subsequently followed remotely by a teleneurology neurohospitalist and those followed in person by a neurohospitalist. Results: There were 447 (23%) patients followed by a teleneurology neurohospitalist and 1459 (77%) patients followed in person by a neurohospitalist. Both groups presented with similar stroke severity. In multivariate analysis, there were no significant differences in discharge disposition, stroke readmission rates, or 90-day modified Rankin Scale (mRS) scores. Length of stay was shorter with teleneurology follow-up. In the subgroup of patients who received tissue plasminogen activator, patients showed no differences in outcomes and had similar complication rates. Teleneurology follow-up resulted in a 3% transfer rate for higher level of care after admission. There remained no difference in outcomes in a subanalysis without Comprehensive Stroke Centers. A higher proportion of non-Hispanic Black patients and a lower proportion of Hispanic patients in the teleneurology follow-up group were possibly due to spoke location demographics. Discussion: Teleneurology follow-up resulted in comparable outcomes to in-person neurology follow-up, with few transfers after admission. For select neurology and ischemic stroke patients, teleneurology follow-up provides an alternative to transfer for hospitals lacking neurology coverage.

Identifiers

PMID36540152
PMCPMC9757113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.